Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Redx Pharma
Redx Pharma
Activities:
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride
The two companies aim to expand the distribution of benzalkonium chloride within Europe
Upperton opens novel development and GMP manufacturing facility
The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development...
Astellas begins construction of manufacturing site in Tralee
600 construction jobs and 100 specialised engineering, science and technology roles will be created from the project
Policy vacuum risks UK becoming a medicines supply backwater
The UK becoming a "backwater" supply marker could jeopardise £18bn of NHS savings from newly off-patented drugs during the next five years
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Ingredients
Redx signs licensing agreement with AstraZeneca for porcupine inhibitor
AstraZeneca will take RXC006 forward into clinical development, targeting fibrotic diseases including idiopathic pulmonary fibrosis
Finance
Redx Pharma appoints Sarah Gordon as non-executive Director
Gordon has been appointed due to deep experience of the biotechnology industry and capital markets
Research & Development
Redx Pharma announces new drug development candidate for fibrosis
First-in-human studies earmarked for 2020
Research & Development
Quay Pharma to supply promising cancer drug for trial
Quay Pharma has reached an agreement with Redx Pharma to manufacture Redx’s breakthrough cancer treatment drug
Research & Development
Redx Pharma set for new HQ at Alderley Park, Cheshire
Will bring together its three subsidiaries Redx Oncology, Redx Anti-Infectives and Redx Immunology onto one site
Research & Development
Redx Pharma launches £24m immunology R&D centre
Receives £4.2m of funding from the UK Government's Regional Growth Fund to be matched with proceeds from AIM listing
Research & Development
Redx Pharma and Pierre Fabre collaborate in skin cancer drug field
Will together develop a small molecule programme for an undisclosed cancer target
Subscribe now